Source:http://linkedlifedata.com/resource/pubmed/id/10367539
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1999-7-8
|
pubmed:abstractText |
To evaluate the therapeutic activity and toxicity of gemcitabine in the treatment of metastatic urothelial carcinoma.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0009-9074
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
150
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
11-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading | |
pubmed:articleTitle |
Single agent 2',2'-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: a phase II study.
|
pubmed:affiliation |
Division Medical Oncology, Centro Catanese di Oncologia, Catania, Italy.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Clinical Trial, Phase II
|